A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women

Breast cancer genetic counseling after diagnosis but before treatment: A pilot study on treatment consequences and psychological impact

(2012) Marijke R. Wevers et al.   PATIENT EDUCATION AND COUNSELING

Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation inBRCA1orBRCA2

(2010) Kathleen E. Malone et al.   JOURNAL OF CLINICAL ONCOLOGY

Update on breast reconstruction in breast cancer

(2009) Patrick Reavey et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing

(2009) E. VAN RIEL et al.   EUROPEAN JOURNAL OF CANCER CARE

Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2009) Monika K. Graeser et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival Analysis of Cancer Risk Reduction Strategies forBRCA1/2Mutation Carriers

(2009) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Penetrance estimates for BRCA1 and BRCA2based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

(2008) D Gareth Evans et al.   BMC CANCER

Predictors of Contralateral Prophylactic Mastectomy in Women With a BRCA1 or BRCA2 Mutation: The Hereditary Breast Cancer Clinical Study Group

(2008) Kelly A. Metcalfe et al.   JOURNAL OF CLINICAL ONCOLOGY